Mounjaro for Weight Loss
Prescribed online through TOM Weight Loss
Mounjaro is the first medication to target two weight-regulating hormones simultaneously, and the clinical results show it. If you've tried other GLP-1 medications without hitting your goals, or you're starting your weight loss journey and want the most effective option available, TOM Weight Loss prescribes Mounjaro online to patients across Texas and Utah.
What Is Mounjaro?
Mounjaro contains tirzepatide, a molecule that works on two separate hormone receptors to reduce appetite and support weight loss. It produces greater average weight loss than any semaglutide-based medication on the market.
Mounjaro and the Dual GIP and GLP-1 Mechanism
Mounjaro was originally FDA-approved for type 2 diabetes, but its weight loss results were so significant that tirzepatide earned its own dedicated obesity approval under the brand name Zepbound. Mounjaro for weight loss is widely prescribed off-label, and its clinical data makes it one of the most effective medications available for sustained weight reduction.
Where Ozempic and Wegovy activate one receptor (GLP-1), Mounjaro's active ingredient, tirzepatide , activates two. It targets GLP-1 just like semaglutide, but it also activates GIP (glucose-dependent insulinotropic polypeptide) receptors. That dual mechanism is what separates Mounjaro's outcomes from everything else currently available.
The SURMOUNT clinical trials showed patients losing an average of 20-22% of their body weight at the highest dose. For context, that's a level of weight loss that until recently was only achievable through bariatric surgery. At TOM Weight Loss, our providers will assess whether Mounjaro or compounded tirzepatide is the right path for you.
Why Patients Choose Mounjaro
- Dual GIP and GLP-1 action for greater results than semaglutide alone
- Average 20-22% body weight loss in SURMOUNT trials
- Once-weekly injection, same simple routine as semaglutide
- Strong option for patients who plateaued on Ozempic or Wegovy
- Six-step titration designed to minimise side effects
- Available as compounded tirzepatide for cost savings
- Physician-managed from first dose through maintenance
- Prescribed and monitored by licensed Texas providers
How Does Mounjaro Work for Weight Loss?
Mounjaro is a dual GIP and GLP-1 receptor agonist. Understanding what that means in practice is key to understanding why it outperforms semaglutide-based medications in clinical trials.
Two Receptors, Not One
GLP-1 medications like Ozempic and Wegovy activate a single receptor. Mounjaro activates two, GLP-1 and GIP, simultaneously. This is the core reason tirzepatide produces stronger and more sustained weight loss than semaglutide alone.
GLP-1 Action
The GLP-1 component of Mounjaro works exactly as it does in semaglutide medications, suppressing appetite, slowing digestion, and signaling fullness to the brain. Patients eat less without feeling deprived.
GIP Action
GIP enhances the body's insulin response, improves how fat is processed and stored, and amplifies the appetite-suppressing effects of GLP-1. This second layer of hormonal action is what makes Mounjaro's outcomes significantly stronger than GLP-1 alone.
Amplified Fullness Signals
With both receptors engaged, Mounjaro produces a stronger and more sustained reduction in hunger than single-receptor medications. Most patients find cravings and appetite quiet down more noticeably than on semaglutide.
Blood Sugar and Metabolic Regulation
Tirzepatide improves insulin sensitivity and blood sugar stability more effectively than GLP-1 agonists alone. This has metabolic benefits beyond weight loss, particularly for patients with insulin resistance or pre-diabetes.
Greater Average Weight Loss
The SURMOUNT trials showed patients losing an average of 20-22% of body weight at the highest dose, with some losing significantly more. That's the strongest weight loss data of any currently available injectable medication.
Mounjaro Dosing - What to Expect
Mounjaro follows a six-step titration schedule reaching a maximum of 15mg weekly. The structured escalation is essential; moving too fast increases side effects, and staying too low limits results. Your TOM Weight Loss provider manages every step.
| Phase | Dose | What typically happens | Provider action |
|---|---|---|---|
| Weeks 1-4 |
2.5mg | Body adjusts to the medication. Appetite changes are mild at this starting dose. Designed for tolerability, not maximum effect. | Baseline check-in, side effect review |
| Weeks 5-8 |
5mg | Noticeable appetite reduction begins. Early weight loss starts for most patients. Most common time for initial side effects to appear. | Dose increase confirmed if tolerated |
| Weeks 9-12 |
7.5mg | Stronger appetite suppression. Steady weight loss continues. Side effects typically settling as the body adapts. | Progress check, tolerability assessment |
| Weeks 13-16 |
10mg | Most patients are seeing significant results by this point. Dual-mechanism benefits fully engaged. | Progress assessment, dose optimisation |
| Weeks 17-20 |
12.5mg | Continued weight loss. Side effects typically well-managed by this stage. Approaching maximum therapeutic dose. | Review and confirm dose escalation |
| Week 21+ |
15mg (maintenance) | Full therapeutic dose reached. Maximum weight loss potential. Not every patient needs to reach 15mg; your provider will assess your individual response. | Long-term plan review |
Mounjaro Side Effects - What You Need to Know
Side effects of Mounjaro are primarily gastrointestinal and most pronounced during the early weeks or when increasing the dose. The structured six-step titration schedule is specifically designed to reduce their severity.
Nausea and Vomiting
The most commonly reported side effects of Mounjaro, particularly at the 5mg and 7.5mg stages where appetite suppression intensifies. For most patients symptoms are mild and ease within 2-4 weeks of each new dose.
Digestive Symptoms
Diarrhea, constipation, and stomach discomfort are most common in the first half of the six-step titration. Eating smaller, lower-fat meals and staying well hydrated helps considerably. Your TOM provider will walk you through practical adjustments at each stage.
Does Mounjaro Make You Tired?
Fatigue is reported by some patients, most often in the first few weeks of treatment or after moving to a higher dose. It typically resolves as the body adapts to tirzepatide's dual-receptor activity. Persistent fatigue is worth flagging with your TOM provider.
Does Mounjaro Cause Hair Loss?
Hair shedding is linked to the rate of weight loss rather than tirzepatide itself. Rapid weight reduction can temporarily disrupt the hair growth cycle, a condition called telogen effluvium. It resolves naturally for most patients within a few months, and adequate protein intake throughout treatment significantly reduces severity.
Less Common but Serious
Rare but reported: pancreatitis, gallbladder disease, low blood sugar in patients also taking insulin, and allergic reactions. Because Mounjaro targets two receptors, its interaction profile with other diabetes medications is worth careful review. Your TOM provider will go through all relevant risks before prescribing.
How Long Do Side Effects Last?
Most gastrointestinal side effects peak within the first 1-2 weeks of a new dose and ease significantly by week 3-4. Mounjaro's six-step schedule gives more adjustment windows than shorter titration protocols, which is one reason TOM providers follow it carefully rather than rushing to higher doses.
Mounjaro vs. Other Weight Loss Medications
The key distinction with Mounjaro isn't just the numbers; it's the mechanism. Here's how it compares to the other medications available through TOM Weight Loss.
| Medication | Active Ingredient | Mechanism | FDA Approval | Max Weekly Dose | Avg. Weight Loss |
|---|---|---|---|---|---|
| Mounjaro | Tirzepatide | GLP-1 + GIP dual agonist | Type 2 diabetes | 15mg | 20-22% |
| Zepbound | Tirzepatide | GLP-1 + GIP dual agonist | Chronic weight management | 15mg | 20-22% |
| Wegovy | Semaglutide | GLP-1 agonist | Chronic weight management | 2.4mg | 15-17% |
| Ozempic | Semaglutide | GLP-1 agonist | Type 2 diabetes | 2mg | 10-15% |
Mounjaro and Zepbound contain the same molecule. The difference is FDA indication. For patients using tirzepatide purely for weight loss, your provider will advise on which is most appropriate. Not sure where to start? Check our GLP-1 eligibility guide →
Who Qualifies for Mounjaro?
Mounjaro is typically prescribed for weight loss to patients who meet standard obesity medicine criteria. It's also worth discussing with your provider if you've previously tried semaglutide without achieving your goals.
BMI and eligibility requirements
Mounjaro is typically prescribed for weight loss to patients who meet one of the following:
- BMI of 27+ with at least one weight-related condition (high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea)
- BMI of 30+ regardless of other conditions
- Have tried diet and exercise without sustainable results
- Have plateaued on semaglutide and want to explore a stronger option
Not sure if you qualify? Check our full GLP-1 eligibility guide →
Medical conditions that may affect eligibility
Mounjaro is not suitable for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), or during pregnancy. Patients with a history of pancreatitis should discuss this with their provider before starting.
Your TOM provider will review your full medical history, current medications, and any contraindications before prescribing. This matters especially for tirzepatide given its dual mechanism and interactions with insulin or other diabetes medications.
If Mounjaro isn't the right fit, your provider will discuss alternatives including Zepbound , Wegovy , Ozempic , or oral medications.
How to Get Mounjaro Online Through TOM Weight Loss
Getting started with Mounjaro is fully virtual and straightforward. From your first consultation to receiving your medication, the entire process happens online, with a real licensed physician overseeing every step.
Free Consultation
Meet virtually with a board-certified physician who reviews your goals, health history, and whether Mounjaro or another tirzepatide option is the right fit.
Personalised Plan
Your physician builds your six-step titration schedule and selects whether brand-name Mounjaro or compounded tirzepatide is the most appropriate and cost-effective path.
Prescription and Delivery
Your prescription is fulfilled through a licensed pharmacy and shipped directly to your door, typically within 1-3 days of approval. Stored refrigerated on arrival.
Ongoing Support
Six dose escalation steps means six checkpoints where clinical oversight matters. Your TOM provider monitors progress and adjusts your plan throughout.
The Strongest Weight Loss Medication Available, Prescribed Online
TOM Weight Loss is a Texas-based online weight loss clinic prescribing Mounjaro and compounded tirzepatide to patients across Texas and Utah. If you've tried semaglutide and want more, or you're starting fresh and want the highest-performing option available, our licensed providers will give you an honest assessment of whether Mounjaro is right for your situation.
Mounjaro FAQs
Common questions about Mounjaro for weight loss, dosing, side effects, cost, and how it compares to other medications. Can't find your answer? Call us at 713-568-9101.
Not exactly, and the distinction matters. Mounjaro is a dual GIP and GLP-1 receptor agonist. It activates GLP-1 receptors like Ozempic and Wegovy, but it also activates GIP receptors. That dual mechanism is what makes Mounjaro produce greater average weight loss than single-receptor GLP-1 medications in head-to-head data.
Yes, both contain tirzepatide at identical doses. The difference is FDA indication. Mounjaro is approved for type 2 diabetes; Zepbound is approved specifically for chronic weight management. For patients using tirzepatide purely for weight loss, Zepbound is the on-label choice, though Mounjaro is widely and appropriately prescribed off-label for the same purpose. Your TOM provider will advise on which is most suitable.
Mounjaro's dual GIP and GLP-1 action produces greater average weight loss, 20-22% versus 10-15% for semaglutide. Both are effective; the right choice depends on your health history, tolerability, goals, and budget. Patients who have plateaued on semaglutide often see stronger results after transitioning to tirzepatide. Your TOM provider will help you weigh the options.
Brand-name Mounjaro lists at approximately $1,000-1,200 per month without insurance. Coverage for off-label weight loss use is inconsistent across plans. Compounded tirzepatide is significantly more affordable and contains the same active ingredient. Through TOM Weight Loss, compounded tirzepatide is available from $249/month. Our team will walk you through every option during your consultation.
For most patients, gastrointestinal side effects peak in the first 2-4 weeks of a new dose and ease significantly after that. Moving through the six-step titration slowly, as TOM Weight Loss providers are trained to do, keeps side effects manageable. If side effects are persistent or severe at any stage, your provider can adjust the pace of dose escalation.
Hair shedding has been reported by some patients, but it's generally attributed to rapid weight loss rather than tirzepatide itself. When the body loses weight quickly it can temporarily shift the hair growth cycle, a phenomenon called telogen effluvium. For most patients it resolves within a few months. Adequate protein intake and nutritional support help minimise it.
Fatigue is a reported side effect, most commonly in the early weeks of treatment or following a dose increase. It typically resolves as your body adjusts. If fatigue is persistent or affecting your quality of life, your TOM Weight Loss provider can assess whether a dose adjustment is needed.
Yes. Mounjaro should be stored in the refrigerator at 36-46°F (2-8°C). If needed, it can be kept at room temperature up to 86°F (30°C) for up to 21 days. Do not freeze. Your provider will include full storage and handling instructions with your prescription.
Yes. Transitioning from semaglutide to tirzepatide is a common and clinically appropriate move for patients who want stronger results or have plateaued on their current medication. Your TOM Weight Loss provider will advise on the right timing and starting dose for the transition.
Get Started With Mounjaro Through TOM Weight Loss
Mounjaro represents a genuine step forward in what medication-assisted weight loss can achieve. Whether you're starting fresh or you've hit a wall on semaglutide, TOM Weight Loss prescribes Mounjaro and compounded tirzepatide to patients across Texas and Utah, with real physician oversight and personalised plans built around your goals and budget.
Prescription required. Not all patients qualify. Physician evaluation required prior to treatment. This page is for informational purposes and does not constitute medical advice. TOM Weight Loss provides telehealth weight management services across Texas and Utah. Results vary.
